Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
J Gynecol Obstet Hum Reprod ; 53(1): 102703, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38040334

ABSTRACT

INTRODUCTION: Indocyanine green (ICG) for axillary sentinel lymph node (SLN) detection in early breast cancer is at least equivalent to radioisotopic and/or colorimetric techniques. This procedure has not yet been recommended by learned societies in France. Following the recent drug approval of Infracyanin ® in this indication, we wished to study the use of ICG in France. METHODS: We conducted a web-based survey among members of multiple French breast cancer societies throughout November 2021. The survey assessed the profile of the respondent, the use or not of ICG for the detection of SLN in breast cancer, the technique used and the opinion of non-users and their expectations on the subject. RESULTS: Seventy-five surgeons participated. More than a third (37 %) have been using ICG for the detection of SLN in breast cancer for 2 to 3 years. Technique was highly variable. According to 82.1 % of the respondents, less than 20 procedures are necessary to master the use of ICG. The main advantage reported for this method is the reduction of organizational constraints. The obstacles to the use of the ICG are the near infra-red camera equipment, but also the lack of validation by the French guidelines. Among non-users, 83 % would like to develop this technique in their center and 72.3 % are interested in training on this subject. CONCLUSION: This work highlights the need for French learned societies to take a stand on this issue but also the need to carry out studies on the technical aspects in order to standardise practices.


Subject(s)
Breast Neoplasms , Sentinel Lymph Node Biopsy , Humans , Female , Indocyanine Green , Breast Neoplasms/pathology , Coloring Agents , France
2.
Ann Chir Plast Esthet ; 68(2): 167-172, 2023 Apr.
Article in French | MEDLINE | ID: mdl-36463024

ABSTRACT

Lipofilling is a well-known procedure, initially described by Coleman in 1991. Many cases of fat embolism following this procedure are published. Our patient had a common carotid fat embolism after a temporal autologous fat graft.


Subject(s)
Embolism, Fat , Pulmonary Embolism , Humans , Adipose Tissue/transplantation , Embolism, Fat/etiology , Carotid Artery, Common , Transplantation, Autologous/methods
3.
Eur J Obstet Gynecol Reprod Biol ; 244: 185-189, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31771801

ABSTRACT

OBJECTIVES: The main objective of this study was to assess the induction-to-delivery interval with or without the use of osmotic dilators for induced abortion. As secondary objectives, women outcomes were assessed. STUDY DESIGN: This retrospective single-center observational before and after study reviewed records from a university hospital maternity unit from 2002 through 2016 and included all women undergoing abortion for medical reasons at and after 14 weeks of gestation. Two groups were compared: group "no dilators", which used first misoprostol without dilators, and group "dilators", which used osmotic dilators before misoprostol administration. The main outcome was the induction-to-delivery interval. RESULTS: The study included 491 women: 383 in group "no dilators" and 108 in group "dilators". The induction-delivery interval was significantly lower in the group "dilators" compared to "no dilators" (427.7 min vs 639.7 min, P < 0.001), as was the cumulative misoprostol dose (990 µg vs 1449 µg, P < 0.001). The delivery rate within 6 h was significantly higher in the "dilators" group compared to "no dilators" group (50.0% vs 29.8%, P = 0.002). CONCLUSION: The use of osmotic dilators for cervical ripening before administration of misoprostol for induced abortion appears to be effective in reducing the induction-delivery interval.


Subject(s)
Abortion, Induced/methods , Labor, Induced/methods , Polymers , Abortifacient Agents, Nonsteroidal/administration & dosage , Abortifacient Agents, Steroidal/administration & dosage , Adult , Female , Humans , Mifepristone/administration & dosage , Misoprostol/administration & dosage , Pregnancy , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL